Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

Perioperative durvalumab plus neoadjuvant chemotherapy led to significant improvements in event-free survival and overall survival as compared with neoadjuvant chemotherapy alone. (Funded by AstraZeneca; NIAGARA ClinicalTrials.gov number, NCT03732677; EudraCT number, 2018-001811-59.).

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2024-09-15
DOI
https://doi.org/10.1056/nejmoa2408154
Citations
274
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
156.94

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

Lorenzo Antonuzzo, Joshua J. Meeks, Matthew D. Galsky, Stephan Hois et al.
274 citations
New England Journal of Medicine
Bladder and Urothelial Cancer Treatments
156.94
article

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

Lorenzo Antonuzzo, Joshua J. Meeks, Matthew D. Galsky, Stephan Hois, Hikmat A Al‐Ahmadie, Mustafa Özgüroğlu, Michiel S. van der Heijden, James W.F. Catto, Vagif Atduev, Yousef Zakharia, Toan Quang Vu, Ashok Kumar Gupta, Ariel Galapo Kann, Hiroyuki Nishiyama, Thomas Powles, Cristina Suárez, Florian Roghmann, J. Armstrong, Moran Gadot, Tomáš Büchler, Paweł Wiechno, Bernhard J. Eigl, Niara Oliveira, Tae‐Hwan Kim, Chao-Hsiang Chang
article en
274 citations

Abstract

Perioperative durvalumab plus neoadjuvant chemotherapy led to significant improvements in event-free survival and overall survival as compared with neoadjuvant chemotherapy alone. (Funded by AstraZeneca; NIAGARA ClinicalTrials.gov number, NCT03732677; EudraCT number, 2018-001811-59.).

New England Journal of MedicineVol. 391(19)
Queen Mary University of London (GB)
AstraZeneca
Openalex Percentile: Top 0%
Bladder and Urothelial Cancer Treatments
156.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.